European Journal of Medicinal Chemistry p. 45 - 54 (1994)
Update date:2022-08-16
Topics:
Lazar, S.
Jabbouri, S.
Moisand, C.
Noeel-Hocquet, S.
Meunier, J.C.
et al.
Prodrugs of the two opiate antagonists naloxone and naltrexone, in particular the 3-monophosphate, 3-triphosphate, 3-monosulfate and 3,14-disulfate esters, have been synthesized and evaluated for: i) their ability to bind opioid receptors in vitro; and ii) their stability in both space and time upon entrapment into ex vivo human red blood cells (RBC).We find that, unlike the other esters, the mono- and triphosphate esters, of naloxone and naltrexone retain high (in the nmol range) affinities especially for μ- and κ-opioid receptors.Owing to their hydrophilic nature, the two esters could possibly help in certain types of pharmacological experiments.Morover, upon entrapment into human RBC, the triphosphate esters of naloxone and naltrexone display considerable ex vivo intracellular stability. phosphate and sulfate esters of naloxone and naltrexone / opiate antagonists / μ- δ- and κ-opioid receptors / equilibrium binding / encapsulation / red blood cells / metabolic stability
View MoreHenan Techway Chemical Co.,Ltd.
website:http://www.techwaychem.com
Contact:+86-371-66380080
Address:No.27 Shunhe Road,
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Shandong Loyal Chemical industrial Co.,Ltd
Contact:0533-7451788
Address:Linzi Chemical Industrial Park, Zibo, Shandong Province
Shanghai Sunwise Chemical Co., Ltd
website:http://www.sunwisechem.com
Contact:86-021-33883180
Address:Room 10E, Building G, Westlink Center, No. 2337 Gudai Road, Minhang District, Shanghai, China PC: 201100
Contact:0512-63006287
Address:no.88.YISHENG Road,etdz-WUJIANG,SUZHOU,CHINA
Doi:10.1002/hlca.19970800212
(1997)Doi:10.1016/j.bmcl.2004.11.014
(2005)Doi:10.1016/j.jmmm.2009.03.039
(2009)Doi:10.1016/j.saa.2012.02.070
(2012)Doi:10.1021/jacs.5b13500
(2016)Doi:10.1016/j.jallcom.2009.05.013
(2009)